Comparison between Baweja Studios IPO and Docmode Health Technologies IPO.
Baweja Studios IPO is a SME Fixed Price IPO proposed to list at NSE SME while Docmode Health Technologies IPO is a SME Fixed Price proposed to list at NSE SME.
| Baweja Studios IPO | Docmode Health Technologies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Fedex Securities Pvt.Ltd. | Fedex Securities Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | NNM Securities Pvt.Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Baweja Studios IPO is up to ₹92.02 Cr whereas the issue size of the Docmode Health Technologies IPO is up to ₹6.37 Cr. The final issue price of Baweja Studios IPO is ₹180.00 per share and of Docmode Health Technologies IPO is ₹79.00 per share.
| Baweja Studios IPO | Docmode Health Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹170.00 per share | |
| Issue Price (Upper) | ₹180.00 per share | |
| Issue Price (Final) | ₹180.00 per share | ₹79.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 800 shares | 1600 shares |
| Fresh Issue Size | 37,12,000 shares | 8,06,400 shares |
| Fresh Issue Size (Amount) | up to ₹66.82 Cr | up to ₹6.37 Cr |
| OFS Issue Size | 14,00,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹25.20 Cr | up to ₹0.00 Cr |
| Issue Size Total | 51,12,000 shares | 8,06,400 shares |
| Issue Size Total (Amount) | up to ₹92.02 Cr | up to ₹6.37 Cr |
Baweja Studios IPO opens on Jan 29, 2024, while Docmode Health Technologies IPO opens on Jan 25, 2024. The closing date of Baweja Studios IPO and Docmode Health Technologies IPO is Feb 01, 2024, and Jan 30, 2024, respectively.
| Baweja Studios IPO | Docmode Health Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Jan 25, 2024 | |
| Issue Open | Jan 29, 2024 | Jan 25, 2024 |
| Issue Close | Feb 01, 2024 | Jan 30, 2024 |
| Basis Of Allotment (Tentative) | Feb 02, 2024 | Jan 31, 2024 |
| Initiation of Refunds (Tentative) | Feb 05, 2024 | Feb 01, 2024 |
| Credit of Share (Tentative) | Feb 05, 2024 | Feb 01, 2024 |
| Listing date (Tentative) | Feb 06, 2024 | Feb 02, 2024 |
| Anchor Lockin End date 1 | Mar 03, 2024 | |
| Anchor Lockin End date 2 | May 02, 2024 |
Baweja Studios IPO P/E ratio is 32.59, as compared to Docmode Health Technologies IPO P/E ratio of 9.3.
| Baweja Studios IPO | Docmode Health Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 65.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 47.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.59 | 9.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹331.69 Cr. | ₹24.83 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 40.12% | 80.03% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 52.55% | 22.46% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.07 | 2.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.52 | ₹8.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 40.12% | 56.06% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Baweja Studios IPO Retail Individual Investors (RII) are offered 22,84,000 shares while in Docmode Health Technologies IPO retail investors are offered 22,84,000 shares. Qualified Institutional Buyers (QIB) are offered 2,17,600 shares in Baweja Studios IPO and in Docmode Health Technologies IPO.
| Baweja Studios IPO | Docmode Health Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 3,26,400 shares | |
| Market Maker Reservation | 2,88,000 shares | 43,200 shares |
| QIB | 2,17,600 shares | |
| NII | 22,84,000 shares | 4,03,200 shares |
| RII | 22,84,000 shares | 4,03,200 shares |
| Employee | ||
| Others | ||
| Total | 51,12,000 shares | 8,06,400 shares |
Baweja Studios IPO subscribed 2.62x in total, whereas Docmode Health Technologies IPO subscribed 215.24x.
| Baweja Studios IPO | Docmode Health Technologies IPO | |
|---|---|---|
| QIB (times) | 2.17x | |
| NII (times) | 1.08x | 194.90x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.20x | 230.38x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.62x | 215.24x |
